Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
2 hedge funds and large institutions have $3.44M invested in Albany Molecular Research Inc in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 133 closing their positions.
99% less funds holding
Funds holding: 136 → 2 (-134)
99% less capital invested
Capital invested by funds: $677M → $3.44M (-$674M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 133
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$871K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$80M |
| 2 |
ACM
American Capital Management
New York
|
-$55.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.9M |
| 5 |
Citigroup
New York
|
-$30.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
126
Advisor Group
Phoenix,
Arizona
| – | -$7K | -317 | Closed |
|
|
PA
127
Parallel Advisors
San Francisco,
California
| – | -$5K | -216 | Closed |
|
|
OFW
128
Omnia Family Wealth
Aventura,
Florida
| – | -$4K | -186 | Closed |
|
129
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -171 | Closed |
|
|
GT
130
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$2K | -163 | Closed |
|
|
NFG
131
Next Financial Group
Houston,
Texas
| – | -$2K | -100 | Closed |
|
|
IA
132
IFP Advisors
Tampa,
Florida
| – | -$1K | -60 | Closed |
|
133
SEI Investments
Oaks,
Pennsylvania
| – | -$1K | -44 | Closed |
|
AMRI Hedge Fund Activity: Q3 2017 in Review
2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2017, worth a combined $3.44M — down 99% from $677M a quarter earlier.
Sellers outnumbered buyers: 133 funds closed out of AMRI and 0 opened new positions — a net loss of 133 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Ancora Advisors, adding an estimated $871K. The largest seller was BlackRock, exiting entirely with an estimated $80M sold.
- 2 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2017, down from 136 in Q2 2017.
- Funds reported $3.44M of Albany Molecular Research Inc stock for Q3 2017, down 99% quarter-over-quarter.
- 0 funds opened new Albany Molecular Research Inc positions in Q3 2017 and 133 closed out, a net change of -133 holders.
- The largest Albany Molecular Research Inc buyer in Q3 2017 was Ancora Advisors, an estimated $871K added.
- The largest Albany Molecular Research Inc seller in Q3 2017 was BlackRock, an estimated $80M sold.
Based on aggregated 13F filings for Q3 2017.